CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
with zimberelimab, and domvanalimab in combination with zimberelimab and etrumadenant (AB928) in front-line, PD-L1 positive, metastatic non- ...
Phase 2
Montréal, Canada and 64 other locations
This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non...
Phase 2
Montréal, Canada and 43 other locations
in participants with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with o...
Phase 3
Montréal, Quebec, Canada and 205 other locations
This is a Phase III, randomized, double-blind, placebo-controlled, multi-center international study assessing the activity of durvalumab and chemothe...
Phase 3
Montreal, Quebec, Canada and 230 other locations
This is a phase III randomized open label study designed to compare JDQ443 as monotherapy to docetaxel in participants with advanced non-small...
Phase 3
Montreal, Quebec, Canada and 155 other locations
This study is designed to identify the target Non-Small Cell Lung Cancer (NSCLC) population(s) that over...
Phase 2
Greenfield Park, Quebec, Canada and 252 other locations
Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell...
Phase 3
Greenfield Park, Quebec, Canada and 268 other locations
, early-stage non-small cell lung cancer....
Phase 2
Montreal, Quebec, Canada and 94 other locations
The study is a prospective, randomized controlled phase III trial, to test the efficacy, safety and neurocognitive outcomes of advanced NSCLC patient...
Phase 3
Montreal, Quebec, Canada and 127 other locations
This study is being done to answer the following question: What are the effects of new treatments on non-small cell lung...
Phase 2
Montreal, Quebec, Canada and 8 other locations
Clinical trials
Research sites
Resources
Legal